Skip to content

Non-invasive Testing for End-Stage Chronic Kidney Disease

Noninvasive, Multiplex and Portable Testing of Urea and Potassium to Enable Patient-Centered Monitoring of End-Stage Chronic Kidney Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07777523
Acronym
NiTED
Enrollment
55
Registered
2026-08-20
Start date
2025-10-01
Completion date
2025-12-31
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis Patients, Noninvasive, Potassium Measurement, Renal Disease, Chronic, Renal Disease, End-Stage, Urea in Blood; High

Keywords

PORTABLE TEST, POTASSIUM, CAPILLARY BLOOD, UREA, DIALYSIS, RENAL, ESCKD, DIGITAL, METHOD VALIDATION, MULTIPLEX, NONINVASIVE

Brief summary

This study evaluates the clinical performance of a non-invasive digital diagnostic test (KF4+, developed and manufactured by Gisens Biotech) for the measurement of urea and potassium in capillary blood in patients with end-stage renal disease (ESRD) undergoing dialysis. Measurements obtained using the KF4+ test in capillary blood are compared with hospital laboratory reference methods performed on venous blood samples. The study also assesses the feasibility of determining dialysis efficiency, expressed as Kt/V, using non-invasive samples. The objective is to determine agreement, correlation, and clinical comparability between methods, and to evaluate the use of capillary blood as an alternative to venous sampling in routine dialysis monitoring.

Detailed description

The adequacy of dialysis treatment is traditionally assessed by measuring serum urea and calculating Kt/V, which requires venous blood sampling and laboratory infrastructure. This observational diagnostic study evaluates the use of a portable, bioelectronic point-of-care test (KF4+, Gisens Biotech) for measuring urea and potassium in capillary blood as a non-invasive alternative. KF4+ test is a disposable cartridge based on electrochemical detection of analytes inside. Adult patients with end-stage renal disease undergoing chronic hemodialysis from Hospital Interzonal General de Agudos "General San Martín" are enrolled. Capillary blood samples are collected before and after dialysis sessions and analyzed using the KF4+ digital test. Venous blood samples collected at the same time points are analyzed using standard hospital laboratory reference methods with the autoanalyzer Wiener Lab CMD 800i. Method comparison analyses are performed to evaluate agreement and correlation between capillary and venous measurements. Dialysis efficiency is assessed by calculating Kt/V using urea values obtained from capillary blood and comparing these results with Kt/V calculated from venous blood measurements. The study is conducted at a single hospital center and follows a paired, comparative, observational design. KF4+ results were not used for clinical decision-making.

Interventions

DIAGNOSTIC_TESTKF4+ Noninvasive Test

This is an observational clinical study. The KF4+ is a portable and digital test used to measure urea and potassium concentrations in capillary blood samples. Results are compared with hospital laboratory reference methods performed on venous blood. The KF4+ test is used for measurement only and does not influence clinical management or dialysis prescription.

Sponsors

Gisens Biotech
Lead SponsorINDUSTRY
Universidad Nacional de La Plata
CollaboratorOTHER
Hospital Interzonal General de Agudos General San Martín
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (≥18 years) * Diagnosis of end-stage renal disease * Receiving chronic dialysis treatment * Receiving chronic hemodialysis treatment * Able and willing to provide written informed consent

Exclusion criteria

* Inability to provide informed consent * Any condition that, in the opinion of the investigator, would interfere with participation or data interpretation

Design outcomes

Primary

MeasureTime frameDescription
Agreement and correlation of urea concentrations measured in capillary blood using the KF4+ digital test and in venous blood using the reference laboratory method.Immediately before and immediately after a routine dialysis session.Urea concentrations measured using the KF4+ digital test in capillary blood will be compared with urea concentrations measured using the reference laboratory method in venous blood samples. Agreement between the two methods will be assessed using Bland-Altman analysis, including Bland-Altman plots. Correlation between the two methods will be assessed using Spearman correlation analysis and linear regression. All analyses will be based on paired capillary and venous blood measurements.
Agreement and correlation of potassium concentrations measured in capillary blood using the KF4+ digital test and in venous blood using the reference laboratory methodImmediately before a routine dialysis session.Potassium concentrations measured using the KF4+ digital test in capillary blood will be compared with potassium concentrations measured using the reference laboratory method in venous blood samples. Agreement between the two methods will be assessed using Bland-Altman analysis, including Bland-Altman plots. Correlation between the two methods will be assessed using Spearman correlation analysis and linear regression. All analyses will be based on paired capillary and venous blood measurements.

Secondary

MeasureTime frameDescription
Agreement between Kt/V calculated from capillary blood urea and Kt/V calculated from venous blood urea.Kt/V is calculated immediately after a routine dialysis session using urea levels measured immediately before and immediately after the dialysis session.Agreement between Kt/V calculated using urea concentrations measured in capillary blood with the KF4+ test and Kt/V calculated using urea concentrations measured in venous blood using the reference laboratory method. Agreement between the two methods will be assessed using paired statistical tests. Kt/V will be calculated using the single pool Kt/V equation as indicated by KDIGO 2024 clinical guideline.

Countries

Argentina

Contacts

STUDY_DIRECTOREsteban Piccinini, PhD

Universidad Nacional de La Plata

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026